The CI/PI should notify both the Research Ethics Committee and the sponsor when the study ends, through its scheduled conclusion or early termination.
If you are conducting a clinical trial of an investigational medicinal product (CTIMP), please note there are statutory requirements as to how you must close your study.
Resources
| Type | Where to find |
|---|---|
| Key contacts | Clinical Divisions; JRCO |
| Useful links | NIHR Clinical Trials Toolkit - temp halt or early termination NIHR Clinical Trials Toolkit - trial does not recommence NIHR Clinical Trials Toolkit - end of trial |
| NIHR benchmark | Post NIHR 70-day benchmark |
| Process map links | This activity occurs in the recruitment stage: > Imperial College London as sponsor > Imperial College Hospital NHS Trust as sponsor > Commercial organisation as sponsor > Non-commercial organisation as sponsor |